Specialty Drugs: Data-Driven Strategies to Contain Costs

  • September 11, 2019
  • 12:00 PM – 1:00 PM ET
  • Online

With the ongoing race in the pharmaceutical industry to discover the next silver bullet, the robust specialty drug market continues to grow year after year. We have all seen the statistics:

  • 5% of patients using specialty drugs drive 34% of total health care costs
  • There are 307 new specialty drugs anticipated to launch between 2019-2021

Health insurance providers are constantly looking for innovative solutions to contain the cost without compromising the health of their members. Using data analytics to understand the various trends around all medications that affect the overall cost- frequency of scripts written, brand vs. generic drugs dispensed, medication adherence, population profile, prescribers’ profile, disease burden, and much more. In partnership with PBMs, this powerful set of data analytics can be made available at the individual patient and provider level at the point of care (or place of service), which assists in better clinical decision support consequently leading to lower cost of care.

The webinar, a partnership between CVS Caremark and HDMS, educates health insurance providers on innovative solutions to specialty drug cost containment through the use of data analytics.

Attendees will learn: 

  • Which data insights best inform cost-savings
  • Understand how strategic partnerships help drive down cost and improve outcomes
  • How to drive better physician engagement


Greg Kline
Director, Specialty Solutions
CVS Health

Greg Kline has been with CVS/Coram for over 20 years and currently has responsibility for the development and adoption of integrated and proven specialty and medical benefit management solutions for health plan clients.

Rani Aravamudhan
Senior Clinical Consultant

Rani Aravamudhan is a trained physician with a proven track record in value based care, population health, and analytics.

" "